Recherche
-
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
(Neurotherapeutics. vol. 19, n° 2, pp. 476-490, 2022-03)Article de revueLibre accès -
Brain imaging determinants of functional prognosis after severe endocarditis: a multicenter observational study
(Neurological Sciences. vol. 43, n° 6, pp. 3759-3768, 2022-06)Article de revueLibre accès -
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
(JAMA neurology. vol. 81, n° 3, pp. 273-282, 2024-03-01)Article de revueLibre accès -
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
(Nature Medicine. vol. 29, n° 6, pp. 1487-1499, 2023-06-01)Article de revueLibre accès -
Neuronal diversity of the amygdala and the bed nucleus of the stria terminalis
(Handbook of Behavioral Neuroscience. vol. 26, pp. 63-100, 2020-03-31)Article de revueLibre accès -
Striatopallidal cannabinoid type-1 receptors mediate amphetamine-induced sensitization
(2023-10)Document de travail - Pré-publicationLibre accès -
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43
(Nature Communications. vol. 14, n° 1, pp. 2303, 2023-04-21)Article de revueLibre accès